Reading the unique DNA methylation landscape of the brain: Non-CpG methylation, hydroxymethylation, and MeCP2

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 22, 2015, Pages 6800-6806

  Kinde, Benyam ^a   Gabel, Harrison W ^a   Gilbert, Caitlin S ^a   Griffith, Eric C ^a   Greenberg, Michael E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Hydroxymethylation; MeCP2; Non CpG methylation; Rett syndrome

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; DINUCLEOTIDE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2; PROTEIN; TET1 PROTEIN; TET3 PROTEIN; UNCLASSIFIED DRUG; CYTOSINE; PROTEIN BINDING;

ARTICLE; BRAIN; DNA METHYLATION; GENE CONTROL; METHYLATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN METHYLATION; RETT SYNDROME; ANIMAL; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; NERVE CELL; PHYSIOLOGY;

MAMMALIA;

ANIMALS; BRAIN; CYTOSINE; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; NEURONS; PROTEIN BINDING;

EID: 84930679261     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1411269112     Document Type: Article

References (58)

1. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16(1): 6-21.
2. Kulis M, Esteller M (2010) DNA methylation and cancer. Adv Genet 70:27-56.
3. Huang Y, Rao A (2014) Connections between TET proteins and aberrant DNA modification in cancer. Trends in Genetics 30(10):464-474.
4. Amir RE, et al. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23(2):185-188.
5. Chahrour M, Zoghbi HY (2007) The story of Rett syndrome: From clinic to neurobiology. Neuron 56(3):422-437.
6. Meehan RR, Lewis JD, Bird AP (1992) Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res 20(19):5085-5092.
7. Tatton-Brown K, et al.; Childhood Overgrowth Consortium (2014) Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat Genet 46(4):385-388.
8. Lister R, et al. (2013) Global epigenomic reconfiguration during mammalian brain development. Science 341(6146):1237905.
9. Guo JU, et al. (2014) Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat Neurosci 17(2):215-222.
10. He YF, et al. (2011) Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333(6047):1303-1307.
11. Maiti A, Drohat AC (2011) Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: Potential implications for active demethylation of CpG sites. J Biol Chem 286(41):35334-35338.
12. Bachman M, et al. (2014) 5-Hydroxymethylcytosine is a predominantly stable DNA modification. Nat Chem 6(12):1049-1055.
13. Tucker KL (2001) Methylated cytosine and the brain: A new base for neuroscience. Neuron 30(3):649-652.
14. Okano M, Bell DW, Haber DA, Li E (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3):247-257.
15. Lister R, Ecker JR (2009) Finding the fifth base: Genome-wide sequencing of cytosine methylation. Genome Res 19(6):959-966.
16. Lister R, et al. (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462(7271):315-322.
17. Xie W, et al. (2012) Base-resolution analyses of sequence and parent-of-origin dependent DNA methylation in the mouse genome. Cell 148(4):816-831.
18. Ziller MJ, et al. (2013) Charting a dynamic DNA methylation landscape of the human genome. Nature 500(7463):477-481.
19. Smith ZD, Meissner A (2013) DNA methylation: Roles in mammalian development. Nat Rev Genet 14(3):204-220.
20. Suzuki MM, Bird A (2008) DNA methylation landscapes: Provocative insights from epigenomics. Nat Rev Genet 9(6):465-476.
21. Ziller MJ, et al. (2011) Genomic distribution and inter-sample variation of non-CpG methylation across human cell types. PLoS Genet 7(12):e1002389.
22. Ramsahoye BH, et al. (2000) Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci USA 97(10): 5237-5242.
23. Gabel HW, et al. (2015) Disruption of methyl-CA-dependent long gene repression in Rett syndrome. Nature, in press.
24. Nguyen S, Meletis K, Fu D, Jhaveri S, Jaenisch R (2007) Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespan. Dev Dyn 236(6):1663-1676.
25. Feng J, et al. (2010) Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 13(4):423-430.
26. Baubec T, et al. (2015) Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation. Nature, 10.1038/nature14176.
27. Chen PY, Feng S, Joo JW, Jacobsen SE, Pellegrini M (2011) A comparative analysis of DNA methylation across human embryonic stem cell lines. Genome Biol 12(7):R62.
28. Penn NW, Suwalski R, O'Riley C, Bojanowski K, Yura R (1972) The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem J 126(4):781-790.
29. Kriaucionis S, Heintz N (2009) The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324(5929):929-930.
30. Yu M, et al. (2012) Tet-assisted bisulfite sequencing of 5-hydroxymethylcytosine. Nat Protoc 7(12):2159-2170.
31. Globisch D, et al. (2010) Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS ONE 5(12):e15367.
32. Münzel M, Globisch D, Trindler C, Carell T (2010) Efficient synthesis of 5-hydroxymethylcytosine containing DNA. Org Lett 12(24):5671-5673.
33. Wen L, et al. (2014) Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain. Genome Biol 15(3):R49.
34. Szulwach KE, et al. (2011) 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat Neurosci 14(12):1607-1616.
35. Kaas GA, et al. (2013) TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation. Neuron 79(6):1086-1093.
36. Li X, et al. (2014) Neocortical Tet3-mediated accumulation of 5-hydroxymethylcytosine promotes rapid behavioral adaptation. Proc Natl Acad Sci USA 111(19):7120-7125.
37. Hu L, et al. (2013) Crystal structure of TET2-DNA complex: Insight into TET-mediated 5mC oxidation. Cell 155(7):1545-1555.
38. Mellén M, Ayata P, Dewell S, Kriaucionis S, Heintz N (2012) MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151(7):1417-1430.
39. Guo JU, Su Y, Zhong C, Ming GL, Song H (2011) Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145(3):423-434.
40. Spruijt CG, et al. (2013) Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 152(5):1146-1159.
41. Rudenko A, et al. (2013) Tet1 is critical for neuronal activity-regulated gene expression and memory extinction. Neuron 79(6):1109-1122.
42. Zhang RR, et al. (2013) Tet1 regulates adult hippocampal neurogenesis and cognition. Cell Stem Cell 13(2):237-245.
43. Defossez PA, Stancheva I (2011) Biological functions of methyl-CpG-binding proteins. Prog Mol Biol Transl Sci 101:377-398.
44. Lewis JD, et al. (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69(6):905-914.
45. Kishi N, Macklis JD (2004) MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 27(3):306-321.
46. Skene PJ, et al. (2010) Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell 37(4):457-468.
47. Chen RZ, Akbarian S, Tudor M, Jaenisch R (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27(3): 327-331.
48. Guy J, Hendrich B, Holmes M, Martin JE, Bird A (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27(3):322-326.
49. Lyst MJ, et al. (2013) Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nat Neurosci 16(7):898-902.
50. Guy J, Cheval H, Selfridge J, Bird A (2011) The role of MeCP2 in the brain. Annu Rev Cell Dev Biol 27:631-652.
51. Chahrour M, et al. (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320(5880):1224-1229.
52. Nan X, Meehan RR, Bird A (1993) Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res 21(21):4886-4892.
53. Valinluck V, et al. (2004) Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res 32(14):4100-4108.
54. Hashimoto H, et al. (2012) Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res 40(11):4841-4849.
55. Khrapunov S, et al. (2014) Unusual characteristics of the DNA binding domain of epigenetic regulatory protein MeCP2 determine its binding specificity. Biochemistry 53(21):3379-3391.
56. Cohen S, et al. (2011) Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72(1):72-85.
57. Baker SA, et al. (2013) An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell 152(5):984-996.
58. Li Y, et al. (2013) Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell 13(4):446-458.